Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chubb
Queensland Health
Argus Health
Covington
Baxter
Johnson and Johnson
Medtronic
Cantor Fitzgerald
Julphar

Generated: June 21, 2018

DrugPatentWatch Database Preview

RETROVIR Drug Profile

see a sample report or, see our see our flat-rate plans

« Back to Dashboard

Which patents cover Retrovir, and when can generic versions of Retrovir launch?

Retrovir is a drug marketed by Viiv Hlthcare and is included in four NDAs.

The generic ingredient in RETROVIR is zidovudine. There are twenty-two drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the zidovudine profile page.
Drug patent expirations by year for RETROVIR
Medical Subject Heading (MeSH) Categories for RETROVIR
Synonyms for RETROVIR
(AZT) 1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
(AZT)1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
1-((2R,4R,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
1-((2R,4S,5S)-4-(diazoamino)-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
1-((2R,4S,5S)-4-azido-5-(hydroxymethyl)-tetrahydrofuran-2-yl)-5-methylpyrimidine-2,4(1H,3H)-dione
1-((2R,4S,5S)-4-AZIDO-5-(HYDROXYMETHYL)TETRAHYDROFURAN-2-YL)-5-METHYLPYRIMIDINE-2,4(1H,3H)-DIONE
1-((2R,5S)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
1-((2S,4R,5R)-4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)-5-methylpyrimidine-2,4-(1H,3H)-dione
1-(3-Azido-2,3-dideoxy-beta-D-ribofuranosyl)thymine
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AzddThd, AZT)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (AZT)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione (N3ddThd)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione [AZT]
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(3''-azido-2'',3''-dideoxythymidine)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(azidothymidine, AZT)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(AZT)
1-(4-Azido-5-hydroxymethyl-tetrahydro-furan-2-yl)-5-methyl-1H-pyrimidine-2,4-dione(Zidovudine, AZT)
1-[ -4-azido-5- oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-1,2,3,4-tetrahydropyrimidine-2,4-dione
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methyl-pyrimidine-2,4-dione
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)oxolan-2-yl]-5-methylpyrimidine-2,4-dione
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methyl-pyrimidine-2,4-dione
1-[(2R,4S,5S)-4-azido-5-(hydroxymethyl)tetrahydrofuran-2-yl]-5-methylpyrimidine-2,4(1H,3H)-dione
3-((2S,3S,5R)-2-(hydroxymethyl)-5-(5-methyl-2,4-dioxo-3,4-dihydropyrimidin-1(2H)-yl)tetrahydrofuran-3-yl)triaz-1-en-2-ium-1-ide
3-Azido-1,2,3-trideoxy-1-(3,4-dihydro-5-methyl-2,4-dioxo-1(2H)-pyrimidinyl)-D-erythro- pentofuranuronic acid
3-Azido-3-deoxythymidine
3' Azido 2',3' Dideoxythymidine
3' Azido 3' deoxythymidine
3'-Azido-2',3'-Dideoxythymidine
3'-Azido-2',3'-dideoxythymidine & sCD4(soluble recombinant protein)
3'-Azido-3'-deoxythymidine
3'-Azido-3'-deoxythymidine (AIDS)
3'-Azido-3'-deoxythymidine & CD4-Pseudomonas exotoxin A hybrid
3'-Azido-3'-deoxythymidine & Concanavalin A
3'-Azido-3'-deoxythymidine & Erythropoietin
3'-Azido-3'-deoxythymidine & Heteropolyoxotungstate PM-19
3'-Azido-3'-deoxythymidine & Interleukin-1
3'-Azido-3'-deoxythymidine & Interleukin-2
3'-Azido-3'-deoxythymidine & Interleukin-6
3'-Azido-3'-deoxythymidine & Lithium & Erythropoietin
3'-Azido-3'-deoxythymidine & Lithium & Granulocyte-macrophage colony-stimulating factor
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-1
3'-Azido-3'-deoxythymidine & Lithium & Interleukin-6
3'-Azido-3'-deoxythymidine & Lymphoblastoid Interferon
3'-Azido-3'-deoxythymidine & Recombinant Interferon-.alpha.-2
3'-Azido-3'-deoxythymidine & Sho-Saiko-To
3'-Azido-3'-deoxythymidine, >=98% (HPLC)
3'-Azido-3'-deoxythymidine, >=99.0% (HPLC)
3'-azido-3'-deoxythymidine, AZT
3'-Azido-3'deoxythymidine & Interferon .alpha.
3'-Azido-3'deoxythymidine & Interferon-alpha
3'-Azido-3'deoxythymidine & Nanoparticles (from human serum albumin or polyhexylcyanoacrylate)
3'-Azido-3'deoxythymidine & Recombinant Soluble CD4 & Recombinant Interferon.alpha.A
3'-azido3'-deoxythymidine
3'-deoxy-3'-azido-thymidine
3'-Deoxy-3'-azidothymidine
3''-azido-2'',3''-dideoxythymidine
3''-Azido-3''-deoxy-thymidine
3''-azido-thymidine
3''-Deoxy-3-azidothymidine
3''azido-2''3''-dideoxythymidine
3'azido-3'deoxythymidine
3&prime
3′-Azido-3′-deoxythymidine
30516-87-1
399024-19-2
4-(4-Azido-5-hydroxy-tetrahydro-furan-2-yl)-5-methyl-3H-pyrazine-2,6-dione
4B9XT59T7S
4lhm
AB0012841
AC1L1TKL
AC1Q2OEK
AEe paragraph signa.o paragraph sign
AK321976
AKOS005622576
AKOS015842610
Antiviral AZT
Antiviral, Chemokine Therapeutics
Antiviral, Shanghai Genomics
ANW-26899
Apo-Zidovudine
AS-13019
azidodeoxythymidine
Azidothymidine
Azitidin
AZT
AZT (Antiviral)
AZT & CD4(178)-PE 40
AZT & Colony-stimulating factor 2
AZT & Concanavalin A (ConA)
AZT & EPO
AZT & GM-CSF
AZT & HPA
AZT & IFN-alpha
AZT & IFN.alpha.
AZT & IFNL1
AZT & IFNL2
AZT & IFNL3
AZT & IL-1
AZT & IL-2
AZT & IL-28A
AZT & IL-28B
AZT & IL-29
AZT & IL-6
AZT & Interferon lambda-1
AZT & Interferon lambda-2
AZT & Interferon lambda-3
AZT & Interferon-.alpha.-2
AZT & Interleukin 28A
AZT & Interleukin 28B
AZT & Interleukin 29
AZT & Li & EPO
AZT & Li & GM-CSF
AZT & Li & IL-1
AZT & Li & IL-6
AZT & Lymphoblastoid Interferon
AZT & NP (from PHCA or HSA)
AZT & PM-19
AZT & rIFN.alpha.2
AZT & rsCD4 & rIFN.alpha.A
AZT & rsT4
AZT & sCD4
AZT & srCD4
AZT & SST
AZT Antiviral
AZT TRANSPLACENTAL CARCINOGENESIS STUDY
AZT, Antiviral
AZT+PRO 140
Aztec
BB_NC-1012
BBL033764
BDBM50002692
Beta interferon(rIFN-beta seron) & 3'-Azido-3'-deoxythymidine(AZT)
BPBio1_000403
BRD-K72903603-001-04-6
BSPBio_000365
BSPBio_003153
BW A509U
BW-A 509U
BW-A-509U
BW-A509U
BWA 509U
BWA-509U
BWA509U
C07210
CCG-39924
CCRIS 105
CHEBI:10110
CHEMBL129
Compound S
Cpd S
CPD000058351
CTCE-0422
CTK4I2082
CZ0012
D00413
D01XYJ
D0UF5H
D0YX5A
DB00495
Dendrigen
DivK1c_000524
DR000819
DRG-0004
DS-4152 & AZT
DSSTox_CID_127
DSSTox_GSID_20127
DSSTox_RID_75386
DTXSID8020127
EN300-52518
Flt3 ligand (viral infection) Shanghai
FT-0601543
GTPL4825
HBOMLICNUCNMMY-XLPZGREQSA-N
HMS1921J20
HMS2090G11
HMS2092D06
HMS2096C07
HMS2234K17
HMS3259H17
HMS501K06
HSDB 6515
IDI1_000524
Immunostimulant (viral infection), Shanghai
Interferon AD + 3'-azido-3'-deoxythymidine
Intron A & AZT
J-700147
J10271
K7 [P Ti2 W10 O40]
KBio1_000524
KBio2_001828
KBio2_004396
KBio2_006964
KBio3_002653
KBioGR_000703
KBioSS_001828
KS-00000WOF
Lecithinized superoxide dismutase & Thymidine, 3'-azido-3'-deoxy-
Liposomal AZT-SN-1
Liposomal AZT-SN-3
LS-1159
MCULE-8664408343
Met-SDF-1.beta. & AZT
Met-SDF-1.beta. & Zidovudine
Met-Stromal Cell-derived Factor-1.beta. (Human) & 3'-Azido-3'-deoxythymidine
MFCD00006536
microthornmicro feminineEthOUO
MLS000028548
MLS001055351
MLS001076358
MLS002153202
MLS002222249
MolPort-002-507-286
NC00666
NCGC00014918-01
NCGC00023945-03
NCGC00023945-04
NCGC00023945-05
NCGC00023945-06
NCGC00023945-07
NCGC00023945-08
NCGC00023945-09
NCGC00023945-10
NCGC00023945-12
NCGC00023945-13
NCGC00178237-01
NCGC00178237-02
NCGC00254276-01
NCGC00259752-01
NINDS_000524
Novo-Azt
NSC 602670
NSC-758185
NSC758185
NU003237
NU003238
NU003239
Opera_ID_1602
PC-SOD+AZT
Pharmakon1600-01502109
Prestwick3_000333
Propolis & Thymidine, 3'-azido-3'-deoxy-
Propolis+AZT
Racemic Liposomal AZT
racemic-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
Retrovir (TN)
Retrovir(TM)
Retrovis (TN)
rIFN-beta seron & AZT
S2579
SAM002548971
SBI-0051731.P002
SCHEMBL14615088
SMR000058351
SN-1-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SN-3-dipalmitoylglycerophospho-AZT (in a lipid vesicle)
SPBio_000834
Spectrum_001348
SPECTRUM1502109
Spectrum2_000927
Spectrum3_001507
Spectrum4_000332
Spectrum5_001101
SR-01000000098
SR-01000000098-3
STK801891
Sulfated polysaccharide-peptidoglycan DS-4152 & 3'-Azido-3'-deoxythymidine
Thymidine, 3'-azido-3'-deoxy-
Thymidine, 3'-azido-3'-deoxy- & PRO 140 (Anti-CCR5 monoclonal antibody)
Tox21_110062
Tox21_110062_1
Tox21_110894
Tox21_202203
Tox21_300578
UNII-4B9XT59T7S
W-5037
Z1723414428
ZDV
zidovudin
Zidovudina
Zidovudina [Spanish]
zidovudine
Zidovudine (JAN/USP/INN)
Zidovudine (JP17/USP/INN)
Zidovudine (Retrovir)
ZIDOVUDINE [AZT]
Zidovudine [USAN:INN:BAN:JAN]
Zidovudine [USAN:USP:INN:BAN:JAN]
Zidovudine & IFNL1
Zidovudine & IFNL2
Zidovudine & IFNL3
Zidovudine & IL-28A
Zidovudine & IL-28B
Zidovudine & IL-29
Zidovudine & Interferon lambda-1
Zidovudine & Interferon lambda-2
Zidovudine & Interferon lambda-3
Zidovudine & Interleukin 28A
Zidovudine & Interleukin 28B
Zidovudine & Interleukin 29
Zidovudine EP III
Zidovudine, European Pharmacopoeia (EP) Reference Standard
Zidovudine, pharmaceutical secondary standard; traceability to USP, PhEur and BP
Zidovudine, United States Pharmacopeia (USP) Reference Standard
Zidovudine+PRO 140
Zidovudinum
Zidovudinum [Latin]
ZINC3779042
zudovidine
ZVD

US Patents and Regulatory Information for RETROVIR

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Viiv Hlthcare RETROVIR zidovudine CAPSULE;ORAL 019655-001 Mar 19, 1987 AB RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-001 Dec 19, 1995 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine INJECTABLE;INJECTION 019951-001 Feb 2, 1990 AP RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine SYRUP;ORAL 019910-001 Sep 28, 1989 AA RX Yes Yes ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

Expired US Patents for RETROVIR

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Viiv Hlthcare RETROVIR zidovudine CAPSULE;ORAL 019655-001 Mar 19, 1987 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 ➤ Sign Up ➤ Sign Up
Viiv Hlthcare RETROVIR zidovudine TABLET;ORAL 020518-002 Oct 4, 1996 ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

see a sample report or, see our see our flat-rate plans

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Boehringer Ingelheim
Chinese Patent Office
McKesson
Baxter
QuintilesIMS
Colorcon
Citi
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.